Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testicular Neoplasms | 11 | 2024 | 786 | 3.130 |
Why?
|
Prostatic Neoplasms | 84 | 2023 | 11083 | 2.850 |
Why?
|
Seminoma | 4 | 2023 | 134 | 2.360 |
Why?
|
Endodermal Sinus Tumor | 5 | 2024 | 52 | 2.270 |
Why?
|
Carcinoma, Embryonal | 3 | 2023 | 36 | 1.800 |
Why?
|
Immunohistochemistry | 39 | 2024 | 11022 | 1.570 |
Why?
|
Prostate | 18 | 2023 | 1755 | 1.470 |
Why?
|
Kidney Neoplasms | 24 | 2024 | 4274 | 1.330 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 5 | 2024 | 480 | 1.300 |
Why?
|
Carcinoma, Renal Cell | 18 | 2024 | 3181 | 1.150 |
Why?
|
Urinary Bladder Neoplasms | 12 | 2023 | 2176 | 0.990 |
Why?
|
Carcinoma, Transitional Cell | 8 | 2023 | 790 | 0.920 |
Why?
|
Prostatic Intraepithelial Neoplasia | 4 | 2017 | 80 | 0.890 |
Why?
|
DNA, Neoplasm | 5 | 2016 | 1742 | 0.850 |
Why?
|
Gene Expression Regulation, Neoplastic | 26 | 2023 | 8611 | 0.850 |
Why?
|
Choriocarcinoma | 1 | 2022 | 121 | 0.790 |
Why?
|
Urologic Neoplasms | 3 | 2022 | 310 | 0.780 |
Why?
|
Carcinoma | 6 | 2022 | 2312 | 0.760 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2021 | 35 | 0.740 |
Why?
|
Testis | 4 | 2022 | 780 | 0.740 |
Why?
|
Prostatectomy | 17 | 2021 | 1782 | 0.730 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2021 | 220 | 0.700 |
Why?
|
beta Catenin | 6 | 2024 | 1043 | 0.680 |
Why?
|
Antigens, CD34 | 2 | 2022 | 656 | 0.680 |
Why?
|
Neoplasm Proteins | 5 | 2023 | 3596 | 0.660 |
Why?
|
Polymerase Chain Reaction | 8 | 2016 | 6069 | 0.630 |
Why?
|
Carcinoma, Hepatocellular | 10 | 2019 | 2329 | 0.630 |
Why?
|
Neoplasm Staging | 34 | 2022 | 11206 | 0.620 |
Why?
|
Lung Neoplasms | 17 | 2022 | 13451 | 0.610 |
Why?
|
Melanoma | 9 | 2023 | 5719 | 0.590 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 11 | 2022 | 5389 | 0.590 |
Why?
|
Male | 179 | 2024 | 363691 | 0.590 |
Why?
|
Cysts | 1 | 2023 | 684 | 0.580 |
Why?
|
Liver Neoplasms | 12 | 2019 | 4353 | 0.560 |
Why?
|
Lymphatic Vessels | 1 | 2021 | 355 | 0.560 |
Why?
|
Oncogene Proteins, Fusion | 11 | 2023 | 1608 | 0.540 |
Why?
|
Ovarian Neoplasms | 7 | 2024 | 4900 | 0.530 |
Why?
|
In Situ Hybridization, Fluorescence | 9 | 2024 | 2505 | 0.520 |
Why?
|
Gastrointestinal Stromal Tumors | 6 | 2019 | 616 | 0.510 |
Why?
|
Mutation | 29 | 2024 | 30196 | 0.510 |
Why?
|
Prostate-Specific Antigen | 13 | 2022 | 2464 | 0.510 |
Why?
|
Liver Transplantation | 10 | 2014 | 2412 | 0.500 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2023 | 3655 | 0.490 |
Why?
|
Humans | 234 | 2024 | 765956 | 0.490 |
Why?
|
Aged | 119 | 2024 | 171114 | 0.490 |
Why?
|
Frozen Sections | 3 | 2021 | 153 | 0.490 |
Why?
|
Telomerase | 4 | 2023 | 749 | 0.480 |
Why?
|
Middle Aged | 124 | 2024 | 223004 | 0.470 |
Why?
|
Lymph Nodes | 7 | 2022 | 3454 | 0.440 |
Why?
|
BRCA1 Protein | 4 | 2023 | 1153 | 0.440 |
Why?
|
Carcinoma, Squamous Cell | 7 | 2021 | 4044 | 0.440 |
Why?
|
Neoplasm Invasiveness | 7 | 2023 | 3602 | 0.440 |
Why?
|
Pathology, Molecular | 1 | 2016 | 330 | 0.430 |
Why?
|
Penile Neoplasms | 3 | 2021 | 156 | 0.430 |
Why?
|
Serine Endopeptidases | 6 | 2023 | 1024 | 0.410 |
Why?
|
Leydig Cell Tumor | 2 | 2024 | 26 | 0.410 |
Why?
|
Forkhead Transcription Factors | 2 | 2017 | 1624 | 0.400 |
Why?
|
Prognosis | 38 | 2023 | 29921 | 0.400 |
Why?
|
DNA Mutational Analysis | 6 | 2021 | 4108 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-kit | 6 | 2020 | 723 | 0.390 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 5 | 2019 | 368 | 0.390 |
Why?
|
Tissue Donors | 5 | 2009 | 2395 | 0.380 |
Why?
|
Muscle, Smooth | 1 | 2016 | 931 | 0.380 |
Why?
|
Retrospective Studies | 46 | 2024 | 81515 | 0.380 |
Why?
|
Cystectomy | 1 | 2016 | 604 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-met | 5 | 2021 | 561 | 0.370 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 4562 | 0.370 |
Why?
|
Receptor, erbB-2 | 5 | 2021 | 2593 | 0.350 |
Why?
|
Skin Neoplasms | 9 | 2023 | 5849 | 0.340 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 12 | 2022 | 11868 | 0.340 |
Why?
|
Neoplasm Recurrence, Local | 15 | 2022 | 9373 | 0.330 |
Why?
|
Adult | 84 | 2024 | 223038 | 0.330 |
Why?
|
Neoplasm Metastasis | 12 | 2021 | 4893 | 0.330 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2020 | 2054 | 0.330 |
Why?
|
Protein Kinase Inhibitors | 11 | 2024 | 5696 | 0.320 |
Why?
|
Aged, 80 and over | 41 | 2021 | 59488 | 0.310 |
Why?
|
TOR Serine-Threonine Kinases | 7 | 2023 | 2056 | 0.310 |
Why?
|
Primary Graft Dysfunction | 1 | 2009 | 112 | 0.310 |
Why?
|
Wnt1 Protein | 1 | 2008 | 120 | 0.300 |
Why?
|
Italy | 8 | 2021 | 854 | 0.300 |
Why?
|
Adenocarcinoma | 10 | 2024 | 6364 | 0.300 |
Why?
|
Prostatitis | 2 | 2019 | 102 | 0.290 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 4 | 2020 | 1106 | 0.290 |
Why?
|
Nevus | 2 | 2022 | 205 | 0.290 |
Why?
|
Palmitic Acid | 1 | 2008 | 147 | 0.290 |
Why?
|
Quinazolines | 1 | 2014 | 1364 | 0.280 |
Why?
|
Urogenital Neoplasms | 2 | 2020 | 129 | 0.280 |
Why?
|
Observer Variation | 7 | 2022 | 2615 | 0.280 |
Why?
|
Choline | 3 | 2021 | 510 | 0.270 |
Why?
|
Glypicans | 2 | 2023 | 33 | 0.270 |
Why?
|
Cytoplasm | 3 | 2016 | 1500 | 0.260 |
Why?
|
Genes, BRCA1 | 1 | 2010 | 750 | 0.260 |
Why?
|
Thyroid Neoplasms | 3 | 2016 | 2371 | 0.260 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2017 | 3111 | 0.260 |
Why?
|
Follow-Up Studies | 29 | 2023 | 39194 | 0.260 |
Why?
|
Hematoxylin | 2 | 2023 | 61 | 0.260 |
Why?
|
Eosine Yellowish-(YS) | 2 | 2023 | 70 | 0.260 |
Why?
|
Survival Analysis | 14 | 2022 | 10070 | 0.260 |
Why?
|
Electron Transport Complex II | 3 | 2018 | 53 | 0.260 |
Why?
|
Female | 87 | 2024 | 396101 | 0.260 |
Why?
|
Urothelium | 2 | 2021 | 272 | 0.250 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2019 | 961 | 0.250 |
Why?
|
Proto-Oncogene Proteins | 5 | 2022 | 4520 | 0.250 |
Why?
|
Antigens, Neoplasm | 4 | 2022 | 2002 | 0.250 |
Why?
|
Trans-Activators | 4 | 2016 | 2850 | 0.250 |
Why?
|
Tumor Burden | 4 | 2020 | 1885 | 0.240 |
Why?
|
Predictive Value of Tests | 13 | 2021 | 15398 | 0.240 |
Why?
|
Disease Progression | 18 | 2020 | 13631 | 0.230 |
Why?
|
Gene Expression Profiling | 9 | 2023 | 9524 | 0.230 |
Why?
|
Carboplatin | 3 | 2014 | 789 | 0.230 |
Why?
|
Tumor Suppressor Proteins | 4 | 2019 | 2796 | 0.230 |
Why?
|
Robotics | 2 | 2021 | 809 | 0.220 |
Why?
|
Tissue Array Analysis | 3 | 2021 | 545 | 0.220 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2023 | 64 | 0.220 |
Why?
|
Sequence Deletion | 2 | 2019 | 1495 | 0.220 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2008 | 488 | 0.220 |
Why?
|
Receptors, Adiponectin | 2 | 2015 | 82 | 0.210 |
Why?
|
In Situ Hybridization | 4 | 2021 | 1886 | 0.210 |
Why?
|
Fatty Liver | 1 | 2009 | 807 | 0.210 |
Why?
|
Neoplastic Processes | 1 | 2023 | 35 | 0.210 |
Why?
|
GATA3 Transcription Factor | 1 | 2023 | 163 | 0.210 |
Why?
|
Watchful Waiting | 4 | 2021 | 493 | 0.210 |
Why?
|
Patient Selection | 5 | 2018 | 4255 | 0.210 |
Why?
|
Lymphatic Metastasis | 7 | 2021 | 2887 | 0.210 |
Why?
|
Atrophy | 3 | 2019 | 1635 | 0.200 |
Why?
|
alpha-Fetoproteins | 1 | 2023 | 226 | 0.200 |
Why?
|
Prospective Studies | 28 | 2021 | 54806 | 0.200 |
Why?
|
Biopsy | 12 | 2022 | 6763 | 0.190 |
Why?
|
Survival Rate | 13 | 2021 | 12795 | 0.190 |
Why?
|
Orchiectomy | 4 | 2020 | 460 | 0.190 |
Why?
|
Carcinoma, Papillary | 3 | 2017 | 788 | 0.190 |
Why?
|
PTEN Phosphohydrolase | 4 | 2017 | 1119 | 0.190 |
Why?
|
Acrospiroma | 1 | 2021 | 10 | 0.190 |
Why?
|
Platinum Compounds | 1 | 2022 | 94 | 0.190 |
Why?
|
Adenoma, Sweat Gland | 1 | 2021 | 18 | 0.190 |
Why?
|
Inflammation | 6 | 2023 | 10850 | 0.180 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2019 | 2423 | 0.180 |
Why?
|
Hematopoietic System | 1 | 2021 | 110 | 0.180 |
Why?
|
Crohn Disease | 3 | 2020 | 2283 | 0.180 |
Why?
|
Neoplasms, Bone Tissue | 1 | 2020 | 7 | 0.180 |
Why?
|
Molecular Targeted Therapy | 5 | 2019 | 2822 | 0.170 |
Why?
|
Activins | 1 | 2022 | 210 | 0.170 |
Why?
|
Neoplasms | 7 | 2019 | 22340 | 0.170 |
Why?
|
Genes, BRCA2 | 1 | 2023 | 588 | 0.170 |
Why?
|
RNA, Viral | 4 | 2020 | 2864 | 0.170 |
Why?
|
Succinate Dehydrogenase | 3 | 2019 | 148 | 0.170 |
Why?
|
Early Detection of Cancer | 1 | 2014 | 3236 | 0.170 |
Why?
|
Paraffin Embedding | 3 | 2018 | 301 | 0.170 |
Why?
|
GTP Phosphohydrolases | 2 | 2020 | 523 | 0.170 |
Why?
|
Tissue Fixation | 3 | 2018 | 244 | 0.170 |
Why?
|
Environment | 2 | 2023 | 1114 | 0.170 |
Why?
|
5' Flanking Region | 1 | 2019 | 31 | 0.170 |
Why?
|
Graft Survival | 2 | 2009 | 3890 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 8 | 2022 | 6499 | 0.160 |
Why?
|
Algorithms | 2 | 2020 | 14071 | 0.160 |
Why?
|
Sweat Gland Neoplasms | 1 | 2021 | 110 | 0.160 |
Why?
|
Fibroblast Growth Factor 4 | 1 | 2019 | 28 | 0.160 |
Why?
|
Immunophenotyping | 1 | 2024 | 1866 | 0.160 |
Why?
|
Formaldehyde | 3 | 2018 | 352 | 0.160 |
Why?
|
Receptors, Somatomedin | 1 | 2018 | 57 | 0.160 |
Why?
|
Hematuria | 1 | 2020 | 230 | 0.160 |
Why?
|
Hepacivirus | 3 | 2013 | 1343 | 0.160 |
Why?
|
Treatment Outcome | 21 | 2020 | 65189 | 0.160 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2019 | 950 | 0.150 |
Why?
|
Proportional Hazards Models | 11 | 2019 | 12509 | 0.150 |
Why?
|
Endosonography | 2 | 2020 | 626 | 0.150 |
Why?
|
Antineoplastic Agents | 7 | 2019 | 13648 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2022 | 5337 | 0.150 |
Why?
|
Antioxidants | 2 | 2017 | 1670 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2023 | 2942 | 0.150 |
Why?
|
Hodgkin Disease | 2 | 2017 | 1383 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 360 | 0.150 |
Why?
|
Nevus, Pigmented | 1 | 2020 | 227 | 0.150 |
Why?
|
Gene Amplification | 2 | 2021 | 1091 | 0.150 |
Why?
|
Fluorouracil | 3 | 1992 | 1648 | 0.150 |
Why?
|
Gene Duplication | 1 | 2019 | 317 | 0.150 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2022 | 1624 | 0.150 |
Why?
|
Phenotype | 6 | 2024 | 16721 | 0.150 |
Why?
|
Receptors, Androgen | 5 | 2021 | 1088 | 0.140 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2019 | 533 | 0.140 |
Why?
|
Carmustine | 1 | 1997 | 137 | 0.140 |
Why?
|
Hepatitis C | 4 | 2013 | 1597 | 0.140 |
Why?
|
DNA Helicases | 1 | 2022 | 852 | 0.140 |
Why?
|
Radiology Information Systems | 1 | 2022 | 532 | 0.140 |
Why?
|
Mitoxantrone | 2 | 1995 | 148 | 0.140 |
Why?
|
DNA Fragmentation | 1 | 2017 | 238 | 0.140 |
Why?
|
DNA Modification Methylases | 1 | 2017 | 207 | 0.140 |
Why?
|
Ki-67 Antigen | 4 | 2015 | 629 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 561 | 0.130 |
Why?
|
Immunotherapy | 4 | 2022 | 4752 | 0.130 |
Why?
|
Angiomyolipoma | 2 | 2015 | 190 | 0.130 |
Why?
|
Nephrectomy | 2 | 2019 | 927 | 0.130 |
Why?
|
Carcinoma in Situ | 1 | 2022 | 779 | 0.130 |
Why?
|
Bone Neoplasms | 2 | 2019 | 2567 | 0.130 |
Why?
|
Down-Regulation | 1 | 2023 | 2927 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 618 | 0.130 |
Why?
|
Breast Neoplasms | 7 | 2017 | 21056 | 0.130 |
Why?
|
Young Adult | 14 | 2024 | 59886 | 0.130 |
Why?
|
Pathology, Clinical | 1 | 2020 | 377 | 0.130 |
Why?
|
Nucleic Acids | 1 | 2018 | 193 | 0.130 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 456 | 0.130 |
Why?
|
BRCA2 Protein | 2 | 2023 | 800 | 0.130 |
Why?
|
Membrane Proteins | 5 | 2020 | 7851 | 0.130 |
Why?
|
DNA Repair Enzymes | 1 | 2017 | 342 | 0.130 |
Why?
|
Reproducibility of Results | 11 | 2022 | 20125 | 0.130 |
Why?
|
Disease Susceptibility | 2 | 2019 | 1789 | 0.130 |
Why?
|
RNA, Neoplasm | 2 | 2015 | 745 | 0.130 |
Why?
|
Receptor, IGF Type 1 | 2 | 2018 | 385 | 0.120 |
Why?
|
Nonsteroidal Anti-Androgens | 1 | 2015 | 9 | 0.120 |
Why?
|
Anilides | 1 | 2018 | 415 | 0.120 |
Why?
|
Risk Assessment | 11 | 2020 | 24283 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2018 | 2589 | 0.120 |
Why?
|
Chemoembolization, Therapeutic | 2 | 2014 | 129 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2022 | 3537 | 0.120 |
Why?
|
Estrogen Receptor alpha | 2 | 2017 | 578 | 0.120 |
Why?
|
ROC Curve | 5 | 2018 | 3620 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2015 | 82 | 0.120 |
Why?
|
Brain Neoplasms | 4 | 2010 | 9071 | 0.120 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 1995 | 56 | 0.120 |
Why?
|
Lymph Node Excision | 3 | 2020 | 1259 | 0.120 |
Why?
|
Receptor, Insulin | 1 | 2018 | 837 | 0.120 |
Why?
|
Preoperative Care | 4 | 2014 | 2267 | 0.120 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1385 | 0.120 |
Why?
|
Intestines | 2 | 2017 | 1906 | 0.120 |
Why?
|
Receptors, Progesterone | 2 | 2017 | 1153 | 0.120 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2015 | 67 | 0.110 |
Why?
|
Astrocytoma | 1 | 1999 | 772 | 0.110 |
Why?
|
Adenoma, Oxyphilic | 1 | 2015 | 149 | 0.110 |
Why?
|
Serotonin | 2 | 2016 | 1047 | 0.110 |
Why?
|
Sweden | 4 | 2019 | 1381 | 0.110 |
Why?
|
Cisplatin | 5 | 1996 | 1658 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 995 | 0.110 |
Why?
|
Specimen Handling | 1 | 2018 | 704 | 0.110 |
Why?
|
Transcription Factors | 3 | 2022 | 12131 | 0.110 |
Why?
|
Plaque, Amyloid | 1 | 2018 | 772 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 36532 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2022 | 9249 | 0.110 |
Why?
|
Matched-Pair Analysis | 1 | 2014 | 284 | 0.110 |
Why?
|
Time Factors | 8 | 2018 | 40065 | 0.110 |
Why?
|
DNA Repair | 2 | 2020 | 2048 | 0.110 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 1997 | 614 | 0.110 |
Why?
|
Case-Control Studies | 10 | 2019 | 22222 | 0.110 |
Why?
|
Cyclin D1 | 1 | 2015 | 449 | 0.110 |
Why?
|
Esophagus | 1 | 2019 | 1037 | 0.110 |
Why?
|
Glioma | 3 | 2009 | 3493 | 0.110 |
Why?
|
Inguinal Canal | 1 | 2013 | 71 | 0.110 |
Why?
|
Abdominal Pain | 1 | 2020 | 1069 | 0.110 |
Why?
|
Renal Veins | 1 | 2013 | 103 | 0.100 |
Why?
|
Adolescent | 19 | 2024 | 88832 | 0.100 |
Why?
|
Interferon-alpha | 1 | 1997 | 910 | 0.100 |
Why?
|
Peripheral Nerves | 1 | 2017 | 491 | 0.100 |
Why?
|
Exercise | 2 | 2021 | 5937 | 0.100 |
Why?
|
Genital Neoplasms, Male | 1 | 2013 | 68 | 0.100 |
Why?
|
Exons | 2 | 2015 | 2391 | 0.100 |
Why?
|
Carotenoids | 1 | 2016 | 619 | 0.100 |
Why?
|
Liver | 5 | 2010 | 7562 | 0.100 |
Why?
|
Cadaver | 2 | 2009 | 1359 | 0.100 |
Why?
|
Elasticity Imaging Techniques | 1 | 2017 | 398 | 0.100 |
Why?
|
Amyloidosis | 1 | 2020 | 885 | 0.100 |
Why?
|
Metabolome | 1 | 2019 | 1005 | 0.100 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2016 | 326 | 0.100 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 492 | 0.100 |
Why?
|
Radiopharmaceuticals | 3 | 2018 | 2699 | 0.100 |
Why?
|
Intestinal Mucosa | 4 | 2017 | 3046 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2017 | 2878 | 0.100 |
Why?
|
Gonadal Steroid Hormones | 1 | 2016 | 705 | 0.100 |
Why?
|
Stromal Cells | 1 | 2017 | 1329 | 0.100 |
Why?
|
Intestinal Neoplasms | 1 | 2014 | 313 | 0.100 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 28 | 0.090 |
Why?
|
Neovascularization, Pathologic | 3 | 2016 | 2631 | 0.090 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 2921 | 0.090 |
Why?
|
Sensitivity and Specificity | 7 | 2018 | 14652 | 0.090 |
Why?
|
Metabolomics | 1 | 2020 | 1668 | 0.090 |
Why?
|
Neuroendocrine Tumors | 1 | 2017 | 654 | 0.090 |
Why?
|
Central Nervous System Neoplasms | 1 | 2019 | 916 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 1936 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1534 | 0.090 |
Why?
|
Thromboembolism | 1 | 1997 | 1003 | 0.090 |
Why?
|
Organic Anion Transporters | 1 | 2011 | 101 | 0.090 |
Why?
|
RNA | 2 | 2017 | 2717 | 0.090 |
Why?
|
Remission Induction | 5 | 1997 | 2411 | 0.090 |
Why?
|
Cell Line, Transformed | 2 | 2009 | 858 | 0.090 |
Why?
|
CA-125 Antigen | 2 | 2008 | 283 | 0.090 |
Why?
|
Leucovorin | 1 | 1992 | 641 | 0.090 |
Why?
|
Multivariate Analysis | 5 | 2014 | 12057 | 0.090 |
Why?
|
Fibrosis | 1 | 2017 | 2070 | 0.090 |
Why?
|
Irritable Bowel Syndrome | 1 | 2016 | 454 | 0.090 |
Why?
|
Bronchoscopy | 3 | 2021 | 909 | 0.090 |
Why?
|
Immunomagnetic Separation | 1 | 2010 | 78 | 0.090 |
Why?
|
Neoadjuvant Therapy | 2 | 2014 | 2895 | 0.080 |
Why?
|
Signal Transduction | 10 | 2022 | 23600 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3796 | 0.080 |
Why?
|
MicroRNAs | 2 | 2018 | 3785 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 834 | 0.080 |
Why?
|
Thymoma | 1 | 1991 | 185 | 0.080 |
Why?
|
Genes, erbB-2 | 1 | 2010 | 160 | 0.080 |
Why?
|
Adiponectin | 2 | 2015 | 1119 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 822 | 0.080 |
Why?
|
Lymphocytes | 1 | 2017 | 2599 | 0.080 |
Why?
|
Coloring Agents | 2 | 2022 | 564 | 0.080 |
Why?
|
Up-Regulation | 5 | 2020 | 4137 | 0.080 |
Why?
|
Celiac Disease | 1 | 2017 | 820 | 0.080 |
Why?
|
Gene Fusion | 1 | 2012 | 357 | 0.080 |
Why?
|
DNA Methylation | 2 | 2017 | 4424 | 0.080 |
Why?
|
Deoxycytidine | 1 | 2014 | 889 | 0.080 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2009 | 84 | 0.080 |
Why?
|
RNA, Messenger | 6 | 2019 | 12769 | 0.080 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2011 | 207 | 0.080 |
Why?
|
Apoptosis | 6 | 2018 | 9514 | 0.080 |
Why?
|
Prostatic Hyperplasia | 2 | 2011 | 515 | 0.080 |
Why?
|
Receptors, Calcitriol | 1 | 2011 | 361 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2535 | 0.080 |
Why?
|
Thymus Neoplasms | 1 | 1991 | 270 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2012 | 722 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2023 | 703 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2022 | 728 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2014 | 4913 | 0.080 |
Why?
|
Liver Cirrhosis | 3 | 2010 | 1959 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2010 | 229 | 0.080 |
Why?
|
Hepatitis C Antigens | 1 | 2008 | 35 | 0.080 |
Why?
|
Hepatitis | 1 | 2010 | 227 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1661 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2015 | 1402 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5783 | 0.070 |
Why?
|
Glutathione S-Transferase pi | 1 | 2008 | 99 | 0.070 |
Why?
|
Perforin | 1 | 2008 | 166 | 0.070 |
Why?
|
Area Under Curve | 2 | 2012 | 1638 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2020 | 3584 | 0.070 |
Why?
|
DNA Copy Number Variations | 4 | 2019 | 2045 | 0.070 |
Why?
|
Staining and Labeling | 2 | 2022 | 1072 | 0.070 |
Why?
|
DNA Primers | 2 | 2009 | 2825 | 0.070 |
Why?
|
Interferon-gamma | 1 | 2016 | 3160 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2910 | 0.070 |
Why?
|
Procarbazine | 2 | 1999 | 172 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2845 | 0.070 |
Why?
|
Melanocytes | 3 | 2017 | 515 | 0.070 |
Why?
|
Risk Factors | 13 | 2019 | 74836 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2012 | 975 | 0.070 |
Why?
|
Genitalia, Male | 2 | 2017 | 87 | 0.070 |
Why?
|
Combined Modality Therapy | 5 | 1997 | 8529 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6203 | 0.070 |
Why?
|
Kidney | 3 | 2023 | 7066 | 0.070 |
Why?
|
Granzymes | 1 | 2008 | 278 | 0.070 |
Why?
|
Glioblastoma | 2 | 1999 | 3459 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2152 | 0.070 |
Why?
|
Odds Ratio | 5 | 2019 | 9649 | 0.070 |
Why?
|
Pericardial Effusion | 1 | 1988 | 246 | 0.070 |
Why?
|
Pyridines | 1 | 2018 | 2888 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 434 | 0.070 |
Why?
|
Interferon Type I | 1 | 1990 | 567 | 0.070 |
Why?
|
Reoperation | 1 | 1997 | 4294 | 0.070 |
Why?
|
Cell Line, Tumor | 6 | 2022 | 17075 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 6 | 2019 | 18071 | 0.060 |
Why?
|
Cohort Studies | 10 | 2019 | 41647 | 0.060 |
Why?
|
Ovariectomy | 1 | 2008 | 611 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2017 | 7599 | 0.060 |
Why?
|
Mice, Nude | 2 | 2010 | 3618 | 0.060 |
Why?
|
Leukopenia | 2 | 1997 | 213 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1352 | 0.060 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2012 | 1801 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2017 | 3681 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2021 | 5302 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2010 | 1314 | 0.060 |
Why?
|
Lung | 2 | 2020 | 10033 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2018 | 16047 | 0.060 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 543 | 0.060 |
Why?
|
Obesity | 3 | 2017 | 13075 | 0.060 |
Why?
|
RNA Interference | 2 | 2016 | 2832 | 0.060 |
Why?
|
Graft Rejection | 2 | 2008 | 4499 | 0.060 |
Why?
|
Contrast Media | 2 | 2022 | 5329 | 0.060 |
Why?
|
Pouchitis | 1 | 2005 | 65 | 0.060 |
Why?
|
Logistic Models | 3 | 2016 | 13266 | 0.060 |
Why?
|
Sarcoma | 3 | 2023 | 1802 | 0.060 |
Why?
|
Colorectal Neoplasms | 3 | 2012 | 6942 | 0.060 |
Why?
|
Gene Rearrangement | 3 | 2019 | 1144 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3819 | 0.060 |
Why?
|
Genotype | 6 | 2019 | 13024 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6208 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10383 | 0.050 |
Why?
|
Base Sequence | 3 | 2015 | 12403 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15880 | 0.050 |
Why?
|
Sialyltransferases | 1 | 2003 | 83 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2009 | 1167 | 0.050 |
Why?
|
Oncogenes | 1 | 2009 | 1235 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2017 | 12437 | 0.050 |
Why?
|
Body Mass Index | 4 | 2017 | 13039 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9601 | 0.050 |
Why?
|
Pancreatic Neoplasms | 2 | 2017 | 5444 | 0.050 |
Why?
|
Fetus | 1 | 2010 | 1878 | 0.050 |
Why?
|
Etoposide | 2 | 1996 | 636 | 0.050 |
Why?
|
Ileum | 1 | 2005 | 558 | 0.050 |
Why?
|
Keratin-20 | 1 | 2022 | 31 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5929 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2022 | 12976 | 0.050 |
Why?
|
Platinum | 1 | 2023 | 218 | 0.050 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2002 | 47 | 0.050 |
Why?
|
Translocation, Genetic | 2 | 2020 | 1394 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3316 | 0.050 |
Why?
|
SOXE Transcription Factors | 1 | 2022 | 75 | 0.050 |
Why?
|
MART-1 Antigen | 1 | 2022 | 65 | 0.050 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2008 | 617 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2023 | 312 | 0.050 |
Why?
|
Lymphoproliferative Disorders | 1 | 2005 | 526 | 0.050 |
Why?
|
Child | 7 | 2024 | 80563 | 0.050 |
Why?
|
Cytomegalovirus Infections | 1 | 2008 | 836 | 0.050 |
Why?
|
Genetic Association Studies | 3 | 2019 | 2741 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2017 | 2453 | 0.050 |
Why?
|
Epithelium | 2 | 2017 | 1599 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 1997 | 2229 | 0.050 |
Why?
|
Cysteine Endopeptidases | 2 | 2010 | 542 | 0.050 |
Why?
|
Probiotics | 1 | 2005 | 387 | 0.050 |
Why?
|
Recurrence | 4 | 2013 | 8501 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2023 | 2844 | 0.040 |
Why?
|
Chromosomes | 1 | 2024 | 578 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2022 | 282 | 0.040 |
Why?
|
Vincristine | 2 | 1995 | 1039 | 0.040 |
Why?
|
Cell Hypoxia | 2 | 2013 | 647 | 0.040 |
Why?
|
Doxorubicin | 3 | 1995 | 2230 | 0.040 |
Why?
|
Multienzyme Complexes | 2 | 2010 | 663 | 0.040 |
Why?
|
Germ-Line Mutation | 2 | 2023 | 1884 | 0.040 |
Why?
|
Paclitaxel | 1 | 2008 | 1728 | 0.040 |
Why?
|
Health Care Rationing | 1 | 2003 | 436 | 0.040 |
Why?
|
Cell Proliferation | 4 | 2019 | 10429 | 0.040 |
Why?
|
Cathepsin K | 1 | 2020 | 65 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2021 | 6832 | 0.040 |
Why?
|
Animals | 10 | 2022 | 168759 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3946 | 0.040 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2020 | 77 | 0.040 |
Why?
|
Fibroblast Growth Factor 3 | 1 | 2019 | 17 | 0.040 |
Why?
|
Urinary Bladder Diseases | 1 | 2020 | 166 | 0.040 |
Why?
|
Thrombosis | 1 | 2013 | 2949 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 647 | 0.040 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5786 | 0.040 |
Why?
|
Safety | 1 | 2003 | 1157 | 0.040 |
Why?
|
Organ Transplantation | 2 | 2008 | 1174 | 0.040 |
Why?
|
Dermis | 1 | 2020 | 204 | 0.040 |
Why?
|
Risk | 3 | 2016 | 9591 | 0.040 |
Why?
|
Fixatives | 1 | 2018 | 90 | 0.040 |
Why?
|
Child, Preschool | 5 | 2024 | 42500 | 0.040 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2020 | 170 | 0.040 |
Why?
|
Chromosomes, Human, X | 1 | 2020 | 319 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2019 | 412 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 260 | 0.040 |
Why?
|
Diet | 1 | 2016 | 8086 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6547 | 0.040 |
Why?
|
Nomograms | 1 | 2019 | 235 | 0.040 |
Why?
|
STAT Transcription Factors | 1 | 2018 | 189 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2020 | 335 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2018 | 238 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20660 | 0.030 |
Why?
|
Janus Kinases | 1 | 2018 | 253 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2015 | 3586 | 0.030 |
Why?
|
Genes, cdc | 1 | 1997 | 113 | 0.030 |
Why?
|
Laparoscopy | 2 | 2019 | 2039 | 0.030 |
Why?
|
Paresis | 1 | 1997 | 176 | 0.030 |
Why?
|
Fumarate Hydratase | 1 | 2016 | 55 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1718 | 0.030 |
Why?
|
STAT4 Transcription Factor | 1 | 2016 | 94 | 0.030 |
Why?
|
Protein Stability | 1 | 2018 | 577 | 0.030 |
Why?
|
Patient Care | 1 | 2021 | 629 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2016 | 185 | 0.030 |
Why?
|
Glucose Transporter Type 4 | 1 | 2016 | 240 | 0.030 |
Why?
|
Germinoma | 1 | 1996 | 124 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 566 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1997 | 682 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2022 | 1612 | 0.030 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2016 | 192 | 0.030 |
Why?
|
Microscopy | 1 | 2021 | 901 | 0.030 |
Why?
|
Antigens, CD | 2 | 2005 | 4025 | 0.030 |
Why?
|
DNA Replication | 1 | 2022 | 1433 | 0.030 |
Why?
|
Cell Cycle Proteins | 2 | 1997 | 3430 | 0.030 |
Why?
|
Cytokines | 2 | 2013 | 7421 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2016 | 2867 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 790 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 8927 | 0.030 |
Why?
|
Hepatocytes | 1 | 2002 | 1247 | 0.030 |
Why?
|
Mechlorethamine | 1 | 1995 | 129 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2016 | 366 | 0.030 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1997 | 327 | 0.030 |
Why?
|
Postoperative Complications | 4 | 2019 | 15747 | 0.030 |
Why?
|
Actuarial Analysis | 1 | 1995 | 366 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 2016 | 268 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 663 | 0.030 |
Why?
|
Cytogenetic Analysis | 1 | 2015 | 269 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1997 | 457 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2018 | 453 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2015 | 378 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 1997 | 6493 | 0.030 |
Why?
|
Cell Membrane | 2 | 2016 | 3633 | 0.030 |
Why?
|
Lymphatic Irradiation | 1 | 1995 | 110 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 2007 | 0.030 |
Why?
|
Tamoxifen | 1 | 1999 | 963 | 0.030 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
Mice | 5 | 2022 | 81818 | 0.030 |
Why?
|
Age Factors | 3 | 2019 | 18380 | 0.030 |
Why?
|
Urinary Tract | 1 | 2017 | 305 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1995 | 0.030 |
Why?
|
Immediate-Early Proteins | 1 | 1997 | 444 | 0.030 |
Why?
|
Infusion Pumps | 1 | 1995 | 163 | 0.030 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2016 | 326 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2016 | 615 | 0.030 |
Why?
|
Bleomycin | 1 | 1995 | 491 | 0.030 |
Why?
|
Intestinal Obstruction | 1 | 2017 | 432 | 0.030 |
Why?
|
ras Proteins | 1 | 2019 | 1053 | 0.030 |
Why?
|
Cyclophosphamide | 2 | 1991 | 2228 | 0.030 |
Why?
|
Spermatic Cord | 1 | 2013 | 23 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2016 | 698 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2017 | 682 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 640 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2009 | 314 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2115 | 0.030 |
Why?
|
Vinblastine | 1 | 1995 | 483 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1997 | 660 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 469 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1892 | 0.030 |
Why?
|
Bone Marrow Diseases | 1 | 1995 | 234 | 0.030 |
Why?
|
Liver Function Tests | 2 | 2009 | 525 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 381 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2017 | 26349 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2016 | 595 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2013 | 191 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3672 | 0.030 |
Why?
|
Autocrine Communication | 1 | 2013 | 167 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 864 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9550 | 0.030 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2015 | 409 | 0.020 |
Why?
|
Plant Extracts | 1 | 2016 | 496 | 0.020 |
Why?
|
alpha Catenin | 1 | 2012 | 37 | 0.020 |
Why?
|
Mass Screening | 1 | 2008 | 5445 | 0.020 |
Why?
|
Dacarbazine | 1 | 1995 | 552 | 0.020 |
Why?
|
Transurethral Resection of Prostate | 1 | 2012 | 76 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 616 | 0.020 |
Why?
|
Stathmin | 1 | 2012 | 68 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1997 | 1240 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 798 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 1997 | 1066 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2013 | 328 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 954 | 0.020 |
Why?
|
Keratin-19 | 1 | 2011 | 33 | 0.020 |
Why?
|
Keratin-7 | 1 | 2011 | 55 | 0.020 |
Why?
|
Probability | 1 | 1997 | 2475 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1761 | 0.020 |
Why?
|
Thymus Gland | 1 | 1996 | 1261 | 0.020 |
Why?
|
Body Height | 1 | 2017 | 1562 | 0.020 |
Why?
|
Epididymis | 1 | 2013 | 226 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1490 | 0.020 |
Why?
|
Infant | 3 | 2024 | 36385 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1995 | 1526 | 0.020 |
Why?
|
Histones | 2 | 2013 | 2584 | 0.020 |
Why?
|
Lipoma | 1 | 2013 | 294 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2015 | 774 | 0.020 |
Why?
|
Ifosfamide | 1 | 1991 | 233 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2015 | 878 | 0.020 |
Why?
|
Haplotypes | 1 | 2017 | 2728 | 0.020 |
Why?
|
Anemia | 1 | 2020 | 1511 | 0.020 |
Why?
|
Hepatitis B | 1 | 1996 | 707 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2014 | 728 | 0.020 |
Why?
|
Liposarcoma | 1 | 2013 | 288 | 0.020 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2016 | 730 | 0.020 |
Why?
|
Antibodies | 1 | 2018 | 2417 | 0.020 |
Why?
|
Treatment Failure | 1 | 1996 | 2652 | 0.020 |
Why?
|
Endoscopy | 1 | 2020 | 1841 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2003 | 3800 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2022 | 2803 | 0.020 |
Why?
|
Prednisone | 1 | 1995 | 1565 | 0.020 |
Why?
|
Heparin | 1 | 1997 | 1630 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 933 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2015 | 916 | 0.020 |
Why?
|
Serine | 1 | 2013 | 824 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 637 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7836 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2015 | 784 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1664 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4526 | 0.020 |
Why?
|
Fertilization in Vitro | 1 | 2017 | 1307 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9347 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 166 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1990 | 641 | 0.020 |
Why?
|
Estradiol | 1 | 2016 | 1947 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2009 | 310 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 196 | 0.020 |
Why?
|
Leukemia, Large Granular Lymphocytic | 1 | 2008 | 24 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2009 | 6113 | 0.020 |
Why?
|
Pelvis | 1 | 2013 | 738 | 0.020 |
Why?
|
Leiomyoma | 1 | 2013 | 643 | 0.020 |
Why?
|
Codon | 1 | 2009 | 595 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 1997 | 2080 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 610 | 0.020 |
Why?
|
Incidental Findings | 1 | 2012 | 697 | 0.020 |
Why?
|
Transaminases | 1 | 2008 | 199 | 0.020 |
Why?
|
United States | 4 | 2021 | 72898 | 0.020 |
Why?
|
Rectum | 1 | 2012 | 896 | 0.020 |
Why?
|
Mesothelioma | 1 | 2013 | 771 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 1995 | 1050 | 0.020 |
Why?
|
Bone and Bones | 1 | 2017 | 2554 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4622 | 0.020 |
Why?
|
Cell Division | 2 | 2009 | 4475 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10729 | 0.020 |
Why?
|
Blood Platelets | 1 | 1997 | 2464 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2009 | 1701 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3926 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3432 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2015 | 2132 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2014 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 752 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1644 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2476 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9296 | 0.020 |
Why?
|
Injections | 1 | 1988 | 840 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 1837 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3513 | 0.020 |
Why?
|
Calcium | 1 | 2018 | 5767 | 0.020 |
Why?
|
Testosterone | 1 | 2016 | 2494 | 0.010 |
Why?
|
Models, Biological | 2 | 2013 | 9443 | 0.010 |
Why?
|
Transfection | 1 | 2012 | 5743 | 0.010 |
Why?
|
Muscle Proteins | 1 | 2010 | 1158 | 0.010 |
Why?
|
Mice, SCID | 1 | 2010 | 2630 | 0.010 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2005 | 165 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2011 | 1499 | 0.010 |
Why?
|
Patient Compliance | 1 | 1995 | 2692 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5876 | 0.010 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2004 | 63 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6599 | 0.010 |
Why?
|
Rosaniline Dyes | 1 | 2004 | 52 | 0.010 |
Why?
|
Tandem Repeat Sequences | 1 | 2005 | 184 | 0.010 |
Why?
|
Pericardium | 1 | 1988 | 679 | 0.010 |
Why?
|
Genetic Testing | 1 | 2017 | 3595 | 0.010 |
Why?
|
Mitosis | 1 | 2009 | 1173 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2016 | 3211 | 0.010 |
Why?
|
DNA Damage | 1 | 2013 | 2457 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1744 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15839 | 0.010 |
Why?
|
Tuberous Sclerosis | 1 | 2011 | 1038 | 0.010 |
Why?
|
Intraoperative Period | 1 | 2004 | 508 | 0.010 |
Why?
|
Fluorescence | 1 | 2005 | 753 | 0.010 |
Why?
|
Vitronectin | 1 | 2002 | 40 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5746 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2013 | 1663 | 0.010 |
Why?
|
Heme Oxygenase-1 | 1 | 2005 | 364 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2005 | 648 | 0.010 |
Why?
|
Integrin alphaV | 1 | 2002 | 54 | 0.010 |
Why?
|
Gene Silencing | 1 | 2009 | 1505 | 0.010 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2002 | 29 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1107 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1990 | 4850 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4348 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2005 | 919 | 0.010 |
Why?
|
Health Personnel | 1 | 2015 | 3390 | 0.010 |
Why?
|
Androgens | 1 | 2009 | 1279 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2394 | 0.010 |
Why?
|
Glycosylation | 1 | 2003 | 1100 | 0.010 |
Why?
|
Necrosis | 1 | 2004 | 1617 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1990 | 6309 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 3050 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3222 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18973 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3421 | 0.010 |
Why?
|
Organ Size | 1 | 2004 | 2261 | 0.010 |
Why?
|
Fibronectins | 1 | 2002 | 719 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5881 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3850 | 0.010 |
Why?
|
Software | 1 | 2012 | 4462 | 0.010 |
Why?
|
Physicians | 1 | 2015 | 4588 | 0.010 |
Why?
|
Vitamin D | 1 | 2011 | 3272 | 0.010 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 1997 | 44 | 0.010 |
Why?
|
Protein Phosphatase 1 | 1 | 1997 | 135 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8297 | 0.010 |
Why?
|
Lymphoma | 1 | 2005 | 1897 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2495 | 0.010 |
Why?
|
Glycoproteins | 1 | 2003 | 2195 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2002 | 3089 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 490 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 1997 | 474 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 30258 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11888 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1997 | 440 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1990 | 8041 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 5995 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 1996 | 826 | 0.010 |
Why?
|
Alleles | 1 | 2005 | 6897 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11640 | 0.010 |
Why?
|
Hyperplasia | 1 | 1996 | 1144 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 21480 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 1997 | 1061 | 0.010 |
Why?
|
Neutrophils | 1 | 2005 | 3776 | 0.010 |
Why?
|
Brain | 1 | 1999 | 27178 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7202 | 0.010 |
Why?
|
Cell Movement | 1 | 2002 | 5194 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18294 | 0.010 |
Why?
|
Gene Expression | 1 | 1997 | 7584 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17594 | 0.000 |
Why?
|